Literature DB >> 11945006

Capsular polysaccharide conjugate vaccines against contagious bovine pleuropneumonia: Immune responses and protection in mice.

E R Waite1, J B March.   

Abstract

The immunogenicity of Mycoplasma mycoides subsp. mycoides small colony biotype (MmmSC) vaccines was investigated in BALB/c mice. Groups of mice were vaccinated with either (1) unconjugated capsular polysaccharide (CPS), (2) CPS covalently conjugated to ovalbumin via a carbodiimide reaction, (3) CPS non-covalently bound to latex microspheres, (4) CPS non-covalently complexed with rabbit anti-CPS IgG, and (5) whole inactivated, ultrasonically disrupted (WID) MmmSC. Only mice immunized with the CPS-ovalbumin conjugate exhibited a significant (P<0 small middle dot001) antibody response against CPS. Mice immunized with WID vaccine exhibited a high ELISA antibody titre against non-CPS (protein) antigens only. Mice given WID vaccine were immune against challenge with live MmmSC, and exhibited a significantly reduced degree of mycoplasmaemia (both in incidence and duration) as compared with non-vaccinated controls (P<0 small middle dot001). Mice immunized with the CPS-ovalbumin conjugate did not exhibit a reduction in mycoplasmaemia. The bactericidal activity of rabbit MmmSC-antiserum in an in-vitro growth inhibition test was related to the CPS antibody titre. This was not observed with antisera from the vaccinated mice. None of the mouse antisera exhibited growth inhibiting activity, irrespective of a high CPS or protein antibody titre (CPS-ovalbumin or WID vaccine groups, respectively). Thus, it would seem that protection against an MmmSC-induced mycoplasmaemia in the mouse is based upon cell-mediated rather than humoral immunity. The results suggest that conjugation to ovalbumin significantly increases the antibody response to CPS in the mouse; the lack of bactericidal activity of mouse anti-CPS as compared with rabbit anti-CPS in vitro suggests either that the titre of growth inhibiting antibodies is lower in the mouse or that the mechanism of growth inhibition differs between antibodies of the two species. Copyright Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945006     DOI: 10.1053/jcpa.2001.0540

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  6 in total

1.  Protein-specific analysis of humoral immune responses in a clinical trial for vaccines against contagious bovine pleuropneumonia.

Authors:  Carl Hamsten; Georgina Tjipura-Zaire; Laura McAuliffe; Otto J B Huebschle; Massimo Scacchia; Roger D Ayling; Anja Persson
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

2.  Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype.

Authors:  John B March; Catherine D Jepson; Jason R Clark; Makrina Totsika; Michael J Calcutt
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Rapid detection of contagious bovine pleuropneumonia by a Mycoplasma mycoides subsp. mycoides SC capsular polysaccharide-specific antigen detection latex agglutination test.

Authors:  John B March; Karen Kerr; Benedict Lema
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Ureaplasma diversum Genome Provides New Insights about the Interaction of the Surface Molecules of This Bacterium with the Host.

Authors:  Lucas M Marques; Izadora S Rezende; Maysa S Barbosa; Ana M S Guimarães; Hellen B Martins; Guilherme B Campos; Naíla C do Nascimento; Andrea P Dos Santos; Aline T Amorim; Verena M Santos; Sávio T Farias; Fernanda  C Barrence; Lauro M de Souza; Melissa Buzinhani; Victor E Arana-Chavez; Maria E Zenteno; Gustavo P Amarante-Mendes; Joanne B Messick; Jorge Timenetsky
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

Review 5.  Contagious bovine pleuropneumonia: a rationale for the development of a mucosal sub-unit vaccine.

Authors:  Laurence Dedieu-Engelmann
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2007-08-16       Impact factor: 2.268

Review 6.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.